Patent · US Active

Abiraterone acetate formulation and methods of use

US9889144B2 · kind B2 · utility

5Cited by

9References

20Claims

0Family size

Assignee

iCeutica Inc. · US

Inventors

Maura Murphy · Baltimore, US
Paul Nemeth · Philadelphia, US
H. William Bosch · Via Enrico Fermi, US
Matthew Callahan · Philadelphia, US
Satya Bhamidipati · Philadelphia, US
Jason Coleman · Dallas, US
Christopher C. Hill · Zeeland, US
Marck Norret · Sydney, AU

Key dates

Filing date	Jul 10, 2017
Grant date	Feb 13, 2018
Priority date	—
Expiry date	Jul 10, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2982
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.